153 related articles for article (PubMed ID: 1806568)
1. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome.
Hamilton-Fairley D; Kiddy D; Watson H; Sagle M; Franks S
Hum Reprod; 1991 Sep; 6(8):1095-9. PubMed ID: 1806568
[TBL] [Abstract][Full Text] [Related]
2. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements.
Homburg R; Howles CM
Hum Reprod Update; 1999; 5(5):493-9. PubMed ID: 10582786
[TBL] [Abstract][Full Text] [Related]
3. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
Polson DW; Mason HD; Saldahna MB; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
[TBL] [Abstract][Full Text] [Related]
4. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin.
Hamilton-Fairley D; Kiddy D; Watson H; Paterson C; Franks S
Br J Obstet Gynaecol; 1992 Feb; 99(2):128-31. PubMed ID: 1554664
[TBL] [Abstract][Full Text] [Related]
5. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin.
McFaul PB; Traub AI; Thompson W
Fertil Steril; 1990 May; 53(5):792-7. PubMed ID: 2110070
[TBL] [Abstract][Full Text] [Related]
6. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
Homburg R; Levy T; Ben-Rafael Z
Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
[TBL] [Abstract][Full Text] [Related]
9. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome.
Cheng J; Lv J; Li CY; Xue Y; Huang Z; Zheng W
J Int Med Res; 2010; 38(4):1250-8. PubMed ID: 20925997
[TBL] [Abstract][Full Text] [Related]
11. The polycystic ovary syndrome.
Marut EL
J Reprod Med; 1989 Jan; 34(1 Suppl):104-7. PubMed ID: 2497244
[TBL] [Abstract][Full Text] [Related]
12. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
[TBL] [Abstract][Full Text] [Related]
13. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.
Neyro JL; Barrenetxea G; Montoya F; Rodriguez-Escudero FJ
Hum Reprod; 1991 Feb; 6(2):218-21. PubMed ID: 1905311
[TBL] [Abstract][Full Text] [Related]
14. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
Chen Y; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
[TBL] [Abstract][Full Text] [Related]
15. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.
Prelevic GM; Ginsburg J; Maletic D; Hardiman P; Okolo S; Balint-Peric L; Thomas M; Orskov H
Hum Reprod; 1995 Jan; 10(1):28-32. PubMed ID: 7745065
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and management of ovulatory failure in women with polycystic ovary syndrome.
Franks S; Mason HD; Polson DW; Winston RM; Margara R; Reed MJ
Hum Reprod; 1988 May; 3(4):531-4. PubMed ID: 3134396
[TBL] [Abstract][Full Text] [Related]
17. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins.
Charbonnel B; Krempf M; Blanchard P; Dano F; Delage C
Fertil Steril; 1987 Jun; 47(6):920-4. PubMed ID: 2954858
[TBL] [Abstract][Full Text] [Related]
18. Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome.
McFaul PB; Traub AI; Thompson W
Acta Eur Fertil; 1989; 20(3):157-61. PubMed ID: 2516391
[TBL] [Abstract][Full Text] [Related]
19. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.
Balen AH; Braat DD; West C; Patel A; Jacobs HS
Hum Reprod; 1994 Aug; 9(8):1563-70. PubMed ID: 7989523
[TBL] [Abstract][Full Text] [Related]
20. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
